Page last updated: 2024-08-17

methylene blue and Glycogen Storage Disease Type II

methylene blue has been researched along with Glycogen Storage Disease Type II in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beishuizen, A; Hagemans, ML; Hop, WC; Reuser, AJ; Stigter, RL; van Capelle, CI; van der Beek, NA; van der Ploeg, AT; van Vliet, L; Winkel, LP	1

Trials

1 trial(s) available for methylene blue and Glycogen Storage Disease Type II

Article	Year
PAS-positive lymphocyte vacuoles can be used as diagnostic screening test for Pompe disease. Journal of inherited metabolic disease, 2010, Volume: 33, Issue:2 Topics: Adult; Aged; Child; Child, Preschool; Enzyme Replacement Therapy; Eosine Yellowish-(YS); Female; Glycogen; Glycogen Storage Disease Type II; Humans; Infant; Infant, Newborn; Lymphocytes; Male; Mass Screening; Methylene Blue; Middle Aged; Periodic Acid-Schiff Reaction; ROC Curve; Sensitivity and Specificity; Vacuoles; Young Adult	2010

Article

Year

PAS-positive lymphocyte vacuoles can be used as diagnostic screening test for Pompe disease.

Journal of inherited metabolic disease, 2010, Volume: 33, Issue:2

Topics: Adult; Aged; Child; Child, Preschool; Enzyme Replacement Therapy; Eosine Yellowish-(YS); Female; Glycogen; Glycogen Storage Disease Type II; Humans; Infant; Infant, Newborn; Lymphocytes; Male; Mass Screening; Methylene Blue; Middle Aged; Periodic Acid-Schiff Reaction; ROC Curve; Sensitivity and Specificity; Vacuoles; Young Adult

2010